With funding from AQHA, the Veterinary Genetics Laboratory at UC Davis has successfully created the first scientific approach ...
This approval is based on final data from the PRIMA trial, where the MyChoice CDx Test determined homologous recombination deficiency (HRD) status and was used to stratify advanced ovarian cancer ...
After a heated Las Vegas convention, AQHA members and directors voted to repeal the Two-Year Rule, signaling a major shift in ...
According to data from a new peer-reviewed, real-world study, the "standard" Semen Analysis test can come back "normal" and still miss problems that affect a couple's chances of getting pregnant. SALT ...
The actress, who underwent the serious surgery last year, appeared on the show to chat to Jon Kay, 56, and Sally Nugent, 54, about making her return to stage.
A new computational tool infers changes occurring at the ends of the chromosomes housing our DNA. It does so by detecting structural alterations in cells and tissues captured in images taken of ...
Zacks Investment Research on MSN
NTRA debuts Zenith Genomics next-gen sequencing test for rare diseases
Natera NTRA announced the commercial launch of Zenith genomics, a next-generation whole genome sequencing assay designed to ...
Scientists say that 55 percent of differences in human lifespan are due to genetic makeup, much more than previously believed ...
Scientists traced Leonardo da Vinci’s Y chromosome through living relatives, a breakthrough that may confirm his true burial ...
A new University of Utah-led study has discovered the mechanism behind a decades-old evolutionary mystery-how "selfish chromosomes" cheat the rules of genetic inheritance.
Drugs like Wegovy and Zepbound have been hailed as miracle treatments. But one in 10 people are what scientists call ...
GeneDx Holdings Corp (NASDAQ:WGS) shares dropped 7.8% Thursday following Natera’s commercial launch of Zenith genomics, a whole genome sequencing assay for rare disease diagnosis. Natera Inc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results